Uipath, INC Form 4 insider transactions
NYSE
PATH
Uipath, INCUiPath CEO Daniel Dines sold 45,000 shares of Class A Common Stock for an average price of $15.0243 per share under a Rule 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath CEO and Chairman Daniel Dines filed a Form 4 disclosing a planned sale of 45,000 Class A Common Stock shares on November 3, 2025, under a Rule 10b5-1 plan.
NYSE
PATH
Uipath, INCUiPath CEO and Chairman Daniel Dines sold 45,000 shares of Class A Common Stock for approximately $15.72 per share, executed under a pre-arranged 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath CEO and Chairman Daniel Dines reported the sale of 45,000 Class A Common Stock shares for approximately $15.73 per share under a Rule 10b5-1 plan.
NYSE
PATH
Uipath, INCUiPath CEO Daniel Dines reported the sale of 135,000 Class A Common Stock shares over three days in late October 2025, executed under a Rule 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath CEO Daniel Dines executed a pre-planned sale of 45,000 Class A Common Stock shares at an average price of $15.4578 on October 24, 2025, as disclosed in a Form 4 filing.
NYSE
PATH
Uipath, INCUiPath CEO Daniel Dines sold 45,000 shares of Class A Common Stock for approximately $683,338 under a pre-arranged 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath CEO Daniel Dines sold 45,000 shares of Class A Common Stock for an average price of $15.5312 per share under a pre-arranged 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath's Chief Accounting Officer, Hitesh Ramani, sold 5,000 shares of Class A Common Stock on October 22, 2025, through a pre-arranged 10b5-1 plan.
NYSE
PATH
Uipath, INCUiPath CEO and Chairman Daniel Dines sold 45,000 shares of Class A Common Stock for approximately $15.57 per share under a pre-arranged Rule 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath's Chief Accounting Officer, Hitesh Ramani, reported the sale of 10,000 shares of Class A Common Stock for $15.68 per share under a pre-arranged 10b5-1 plan, with the transaction dated October 21, 2025.
NYSE
PATH
Uipath, INCUiPath CEO Daniel Dines sold 45,000 Class A Common Stock shares for approximately $15.71 each, executed under a Rule 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath's Chief Accounting Officer, Hitesh Ramani, sold 10,000 shares of Class A Common Stock for $15.65 each on October 20, 2025, under a pre-arranged Rule 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath's Chief Accounting Officer, Hitesh Ramani, sold 10,000 shares of Class A Common Stock for an average price of $15.7345 per share, executed under a Rule 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath CEO Daniel Dines sold 45,000 shares of Class A Common Stock for $15.62 per share, executed under a pre-arranged 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath CEO and Chairman Daniel Dines sold 122,734 shares of Class A Common Stock for approximately $2.1 million under a pre-arranged 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath's Chief Accounting Officer, Hitesh Ramani, sold 10,000 shares of Class A Common Stock on October 16, 2025, through a pre-arranged 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath's General Counsel and Chief Legal Officer, Brad Brubaker, sold 27,580 shares of Class A Common Stock for an average price of $16.6761 under a pre-arranged 10b5-1 plan.
NYSE
PATH
Uipath, INCUiPath CEO and Chairman Daniel Dines sold 122,734 shares of Class A Common Stock for approximately $2.07 million under a pre-arranged Rule 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath's Chief Accounting Officer, Hitesh Ramani, sold 20,000 shares of Class A Common Stock for approximately $332,152 through a pre-arranged 10b5-1 plan.
NYSE
PATH
Uipath, INCUiPath's COO & CFO, Ashim Gupta, exercised stock options and subsequently sold a significant number of Class A Common Stock shares under a pre-arranged Rule 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath CEO Daniel Dines sold a total of 245,468 Class A Common Stock shares over two days in October 2025, pursuant to a pre-arranged 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath's Chief Accounting Officer, Hitesh Ramani, reported a planned sale of 10,000 Class A Common Stock shares scheduled for October 13, 2025, under a Rule 10b5-1 plan.
NYSE
PATH
Uipath, INCUiPath CEO Daniel Dines sold 122,734 shares of Class A Common Stock for approximately $2.25 million under a pre-arranged 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath CEO Daniel Dines sold 122,734 shares of Class A Common Stock for an average price of $16.5743 per share, executed under a pre-arranged 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath CEO Daniel Dines sold 122,734 shares of Class A Common Stock for approximately $1.83 million under a pre-arranged 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath CEO Daniel Dines sold 122,733 shares of Class A Common Stock for approximately $1.84 million under a pre-arranged 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath's GC & Chief Legal Officer, Brad Brubaker, sold 66,665 shares of Class A Common Stock for approximately $15.00 per share under a pre-arranged 10b5-1 plan.
NYSE
PATH
Uipath, INCUiPath CEO Daniel Dines sold 122,733 shares of Class A Common Stock for approximately $1.75 million under a pre-arranged 10b5-1 trading plan.
NYSE
PATH
Uipath, INCUiPath CEO Daniel Dines sold 122,733 shares of Class A Common Stock for an average price of $13.0057 per share under a pre-arranged 10b5-1 plan.